Israel
Apowiser Ltd. is revolutionizing the self-care industry with its personalized guidance for Over-The-Counter (OTC) pharmaceuticals and vitamins, minerals, and supplements (VMS) through its advanced Business Intelligence (BI) system. The company's slogan, "ApoWiser: The Digital Bedrock of the OTC Self-Care Revolution," encapsulates its mission to empower consumers in the online marketplace.
Founded in 2021 in Israel, ApoWiser has already made significant strides in the industry, penetrating the platforms of leading health providers and pharmacy chains such as Super-pharm, Superdrug, and Maccabi healthcare services. These integrations have tripled conversion rates and significantly boosted consumer engagement over the past two years.
The latest injection of funds came in the form of a grant investment at 30 January 2023 from MATTER, demonstrating the investors' confidence in ApoWiser's potential in the ever-growing global OTC pharmaceuticals market.
As the company continues to carve a niche in the E-commerce, Health Care, and Pharmaceutical industries, ApoWiser is poised to redefine digital self-care, offering consumers a tailored shopping journey and personalized healthcare solutions.
